Osteoarticular pain and bone mineral density in renal transplantation

Transplant Proc. 2003 Aug;35(5):1769-71. doi: 10.1016/s0041-1345(03)00737-1.

Abstract

Introduction: The reduction of bone mineral density (BMD) levels is an important complication after renal transplantation. The prevalence of nontraumatic lesions may reach 22%. Patients with lower osseous mass suffer the highest number of lesions.

Objective: Evaluate BMD in patients over 30-years old who have undergone renal transplantation more than 1 year prior, who attend a medical facility complaining of osteoarticular pain and were prescribed rest or any analgesia.

Patients and methods: One hundred twenty-three patients who received a renal transplant from a cadaveric donor from 1980 through 2000 were included in the present study to measure BMD levels in the hips and the vertebral column using a densitometer (Hologic 4500 QDR). Our study complied with WHO recommendations, which define normal values as a T score >-1 SD osteopenia as a (T score between <-1 and >-2.5 SD), and osteoporosis as a T score <-2.5 SD. Patients were divided into three groups according to gender and hormonal status. The following clinical and analytic data were collected: age, gender, race, age at onset of menopause, diabetes mellitus (DM), weight, size, retransplantation, period of evolution after transplantation, and parathormone (PTH), creatinine, and renal clearance values.

Results: There were 51 men (41.1%) included. Forty postmenopausal (32.5%) and premenopausal women (26%) were also included. In all patients we observed a correlation between a reduction in BMD values and age, duration post-transplantation, and body weight (P<.05). Reduced BMD levels in premenopausal women were related with lower body weight, (P<.05) and elevated PTH levels (P<.024).

Conclusions: We observed that patients who had undergone transplantation displayed a moderately higher risk of suffering a fracture. Such risk increased in the case of women with more frequent fractures in the vertebral column. In 23.8% of patients reporting osseous pain, there was no reduction in BMD levels. Therefore, we must look for other disorder, responsible for the pain and prescribe adequate treatment.

MeSH terms

  • Adult
  • Body Weight
  • Bone Density / physiology*
  • Female
  • Fractures, Bone / epidemiology
  • Humans
  • Kidney Transplantation / physiology*
  • Male
  • Middle Aged
  • Osteoarthritis / epidemiology
  • Osteoarthritis / physiopathology*
  • Osteoporosis / epidemiology
  • Pain
  • Postmenopause
  • Premenopause
  • Retrospective Studies
  • Risk Factors